Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells

M. A. Hoda, J. Münzker, B. Ghanim, K. Schelch, T. Klikovits, V. Laszlo, E. Sahin, A. Bedeir, A. Lackner, B. Dome, U. Setinek, M. Filipits, M. Eisenbauer, I. Kenessey, S. Török, T. Garay, B. Hegedus, A. Catania, S. Taghavi, W. KlepetkoW. Berger, M. Grusch

Research output: Contribution to journalArticle

Abstract

Background:Activins control the growth of several tumour types including thoracic malignancies. In the present study, we investigated their expression and function in malignant pleural mesothelioma (MPM).Methods:The expression of activins and activin receptors was analysed by quantitative PCR in a panel of MPM cell lines. Activin A expression was further analysed by immunohistochemistry in MPM tissue specimens (N=53). Subsequently, MPM cells were treated with activin A, activin receptor inhibitors or activin-targeting siRNA and the impact on cell viability, proliferation, migration and signalling was assessed.Results:Concomitant expression of activin subunits and receptors was found in all cell lines, and activin A was overexpressed in most cell lines compared with non-malignant mesothelial cells. Similarly, immunohistochemistry demonstrated intense staining of tumour cells for activin A in a subset of patients. Treatment with activin A induced SMAD2 phosphorylation and stimulated clonogenic growth of mesothelioma cells. In contrast, treatment with kinase inhibitors of activin receptors (SB-431542, A-8301) inhibited MPM cell viability, clonogenicity and migration. Silencing of activin A expression by siRNA oligonucleotides further confirmed these results and led to reduced cyclin D1/3 expression.Conclusion:Our study suggests that activin A contributes to the malignant phenotype of MPM cells via regulation of cyclin D and may represent a valuable candidate for therapeutic interference.

Original languageEnglish
Pages (from-to)1978-1986
Number of pages9
JournalBritish Journal of Cancer
Volume107
Issue number12
DOIs
Publication statusPublished - Dec 4 2012

Fingerprint

Activin Receptors
Growth
Activins
Cell Line
Small Interfering RNA
Cell Survival
Immunohistochemistry
Cyclin D
Neoplasms
activin A
Malignant Mesothelioma
Cyclin D1
Mesothelioma
Oligonucleotides
Cell Movement
Phosphotransferases
Thorax
Therapeutics
Phosphorylation
Cell Proliferation

Keywords

  • activin
  • activin receptor
  • mesothelioma
  • SMAD signalling
  • targeted therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hoda, M. A., Münzker, J., Ghanim, B., Schelch, K., Klikovits, T., Laszlo, V., ... Grusch, M. (2012). Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. British Journal of Cancer, 107(12), 1978-1986. https://doi.org/10.1038/bjc.2012.519

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. / Hoda, M. A.; Münzker, J.; Ghanim, B.; Schelch, K.; Klikovits, T.; Laszlo, V.; Sahin, E.; Bedeir, A.; Lackner, A.; Dome, B.; Setinek, U.; Filipits, M.; Eisenbauer, M.; Kenessey, I.; Török, S.; Garay, T.; Hegedus, B.; Catania, A.; Taghavi, S.; Klepetko, W.; Berger, W.; Grusch, M.

In: British Journal of Cancer, Vol. 107, No. 12, 04.12.2012, p. 1978-1986.

Research output: Contribution to journalArticle

Hoda, MA, Münzker, J, Ghanim, B, Schelch, K, Klikovits, T, Laszlo, V, Sahin, E, Bedeir, A, Lackner, A, Dome, B, Setinek, U, Filipits, M, Eisenbauer, M, Kenessey, I, Török, S, Garay, T, Hegedus, B, Catania, A, Taghavi, S, Klepetko, W, Berger, W & Grusch, M 2012, 'Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells', British Journal of Cancer, vol. 107, no. 12, pp. 1978-1986. https://doi.org/10.1038/bjc.2012.519
Hoda MA, Münzker J, Ghanim B, Schelch K, Klikovits T, Laszlo V et al. Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. British Journal of Cancer. 2012 Dec 4;107(12):1978-1986. https://doi.org/10.1038/bjc.2012.519
Hoda, M. A. ; Münzker, J. ; Ghanim, B. ; Schelch, K. ; Klikovits, T. ; Laszlo, V. ; Sahin, E. ; Bedeir, A. ; Lackner, A. ; Dome, B. ; Setinek, U. ; Filipits, M. ; Eisenbauer, M. ; Kenessey, I. ; Török, S. ; Garay, T. ; Hegedus, B. ; Catania, A. ; Taghavi, S. ; Klepetko, W. ; Berger, W. ; Grusch, M. / Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. In: British Journal of Cancer. 2012 ; Vol. 107, No. 12. pp. 1978-1986.
@article{687b393bb8474c07aa6123712d26b8c9,
title = "Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells",
abstract = "Background:Activins control the growth of several tumour types including thoracic malignancies. In the present study, we investigated their expression and function in malignant pleural mesothelioma (MPM).Methods:The expression of activins and activin receptors was analysed by quantitative PCR in a panel of MPM cell lines. Activin A expression was further analysed by immunohistochemistry in MPM tissue specimens (N=53). Subsequently, MPM cells were treated with activin A, activin receptor inhibitors or activin-targeting siRNA and the impact on cell viability, proliferation, migration and signalling was assessed.Results:Concomitant expression of activin subunits and receptors was found in all cell lines, and activin A was overexpressed in most cell lines compared with non-malignant mesothelial cells. Similarly, immunohistochemistry demonstrated intense staining of tumour cells for activin A in a subset of patients. Treatment with activin A induced SMAD2 phosphorylation and stimulated clonogenic growth of mesothelioma cells. In contrast, treatment with kinase inhibitors of activin receptors (SB-431542, A-8301) inhibited MPM cell viability, clonogenicity and migration. Silencing of activin A expression by siRNA oligonucleotides further confirmed these results and led to reduced cyclin D1/3 expression.Conclusion:Our study suggests that activin A contributes to the malignant phenotype of MPM cells via regulation of cyclin D and may represent a valuable candidate for therapeutic interference.",
keywords = "activin, activin receptor, mesothelioma, SMAD signalling, targeted therapy",
author = "Hoda, {M. A.} and J. M{\"u}nzker and B. Ghanim and K. Schelch and T. Klikovits and V. Laszlo and E. Sahin and A. Bedeir and A. Lackner and B. Dome and U. Setinek and M. Filipits and M. Eisenbauer and I. Kenessey and S. T{\"o}r{\"o}k and T. Garay and B. Hegedus and A. Catania and S. Taghavi and W. Klepetko and W. Berger and M. Grusch",
year = "2012",
month = "12",
day = "4",
doi = "10.1038/bjc.2012.519",
language = "English",
volume = "107",
pages = "1978--1986",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells

AU - Hoda, M. A.

AU - Münzker, J.

AU - Ghanim, B.

AU - Schelch, K.

AU - Klikovits, T.

AU - Laszlo, V.

AU - Sahin, E.

AU - Bedeir, A.

AU - Lackner, A.

AU - Dome, B.

AU - Setinek, U.

AU - Filipits, M.

AU - Eisenbauer, M.

AU - Kenessey, I.

AU - Török, S.

AU - Garay, T.

AU - Hegedus, B.

AU - Catania, A.

AU - Taghavi, S.

AU - Klepetko, W.

AU - Berger, W.

AU - Grusch, M.

PY - 2012/12/4

Y1 - 2012/12/4

N2 - Background:Activins control the growth of several tumour types including thoracic malignancies. In the present study, we investigated their expression and function in malignant pleural mesothelioma (MPM).Methods:The expression of activins and activin receptors was analysed by quantitative PCR in a panel of MPM cell lines. Activin A expression was further analysed by immunohistochemistry in MPM tissue specimens (N=53). Subsequently, MPM cells were treated with activin A, activin receptor inhibitors or activin-targeting siRNA and the impact on cell viability, proliferation, migration and signalling was assessed.Results:Concomitant expression of activin subunits and receptors was found in all cell lines, and activin A was overexpressed in most cell lines compared with non-malignant mesothelial cells. Similarly, immunohistochemistry demonstrated intense staining of tumour cells for activin A in a subset of patients. Treatment with activin A induced SMAD2 phosphorylation and stimulated clonogenic growth of mesothelioma cells. In contrast, treatment with kinase inhibitors of activin receptors (SB-431542, A-8301) inhibited MPM cell viability, clonogenicity and migration. Silencing of activin A expression by siRNA oligonucleotides further confirmed these results and led to reduced cyclin D1/3 expression.Conclusion:Our study suggests that activin A contributes to the malignant phenotype of MPM cells via regulation of cyclin D and may represent a valuable candidate for therapeutic interference.

AB - Background:Activins control the growth of several tumour types including thoracic malignancies. In the present study, we investigated their expression and function in malignant pleural mesothelioma (MPM).Methods:The expression of activins and activin receptors was analysed by quantitative PCR in a panel of MPM cell lines. Activin A expression was further analysed by immunohistochemistry in MPM tissue specimens (N=53). Subsequently, MPM cells were treated with activin A, activin receptor inhibitors or activin-targeting siRNA and the impact on cell viability, proliferation, migration and signalling was assessed.Results:Concomitant expression of activin subunits and receptors was found in all cell lines, and activin A was overexpressed in most cell lines compared with non-malignant mesothelial cells. Similarly, immunohistochemistry demonstrated intense staining of tumour cells for activin A in a subset of patients. Treatment with activin A induced SMAD2 phosphorylation and stimulated clonogenic growth of mesothelioma cells. In contrast, treatment with kinase inhibitors of activin receptors (SB-431542, A-8301) inhibited MPM cell viability, clonogenicity and migration. Silencing of activin A expression by siRNA oligonucleotides further confirmed these results and led to reduced cyclin D1/3 expression.Conclusion:Our study suggests that activin A contributes to the malignant phenotype of MPM cells via regulation of cyclin D and may represent a valuable candidate for therapeutic interference.

KW - activin

KW - activin receptor

KW - mesothelioma

KW - SMAD signalling

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84870818616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870818616&partnerID=8YFLogxK

U2 - 10.1038/bjc.2012.519

DO - 10.1038/bjc.2012.519

M3 - Article

C2 - 23169291

AN - SCOPUS:84870818616

VL - 107

SP - 1978

EP - 1986

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 12

ER -